National Disease Research Interchange Elects Board of Directors
May 8 14
National Disease Research Interchange has elected three new members to its board of directors including Mary J.C. Hendrix, PhD, president and scientific director for the Ann and Robert H. Lurie Children's Hospital of Chicago Research Center at Northwestern University's Feinberg School of Medicine in Chicago, Jonathan D. Moreno, PhD, professor of medical ethics and health policy at the University of Pennsylvania and a 2008-09 member of President Barack Obama's transition team, and Howard M. Nathan, president and CEO of the Philadelphia-based nonprofit Gift of Life Donor Program. Jonathan D. Moreno, PhD, is the David and Lyn Silfen University Professor at the University of Pennsylvania and is one of fifteen Penn Integrates Knowledge professors. At Penn he is also professor of medical ethics and health policy, professor of history and sociology of science, and professor of philosophy. Moreno is an elected member of the Institute of Medicine of the National Academy of Sciences and is the U.S. member of the UNESCO International Bioethics Committee. Moreno has served as an adviser to many governmental and non-governmental organizations, including three presidential commissions, the Department of Defense, the Department of Homeland Security, the Department of Health and Human Services, the Centers for Disease Control, the Federal Bureau of Investigation, the Howard Hughes Medical Institute, and the Bill and Melinda Gates Foundation.
National Disease Research Interchange Gets $5.9 Million by National Institutes of Health for Genotype-Tissue Project Scale Up
May 16 13
National Disease Research Interchange has been awarded $5,955,435 by the National Institutes of Health for the next phase of human tissue collection for the Genotype-Tissue Expression (GTEx) project--an NIH initiative begun in 2010 to investigate how genetic variation may relate to gene expression and its correlation with disease. NDRI and its partner organizations will use the funding over the next 15 months to procure 250 organ and tissue donors for researchers. The scale up is a 30-month project scheduled in 2, 15-month phases, with a goal of sourcing 700 additional donors. The $5.9 million awarded to NDRI is for the first, 15-month phase, during which NDRI will work with 5 organ procurement organizations to collect 150 organ donors and 100 tissue donors.
National Disease Research Interchange Hires Gene C. Kopen as Vice President, Corporate Relations
Feb 25 13
National Disease Research Interchange hired Gene C. Kopen as vice president, corporate relations. Kopen had been senior vice president, technology development, for Garnet Biotherapeutics.